For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241115:nRSO3345Ma&default-theme=true
RNS Number : 3345M Spire Healthcare Group PLC 15 November 2024
15 November 2024
Spire Healthcare Group plc
Transaction in own shares
Spire Healthcare Group plc (the "Company") announces that, in accordance with
the terms of its share buyback programme announced on 31 October 2024 (the
"Share Buyback Programme") and the authority granted by its shareholders at
the Company's 2024 Annual General Meeting held on 9 May 2024, it has purchased
the following number of its ordinary shares of 1 pence each ("Shares") on the
London Stock Exchange through Numis Securities Limited ("Deutsche Numis"):
Date of purchase: 14 November 2024
Number of Shares purchased: 38,601
Highest price paid per Share (GBp): 218.50
Lowest price paid per Share (GBp): 215.50
Volume weighted average price paid per Share (GBp): 217.5765
Broker: Deutsche Numis
Trading venue: London Stock Exchange
The purchased Shares will be cancelled.
Following the purchase of these Shares, the remaining number of Shares in
issue will be 403,644,688. The Company does not hold any Shares in treasury.
Therefore, the total number of voting rights in the Company is 403,644,688.
This figure may be used by shareholders as the denominator for the calculation
by which they can determine if they are required to notify their interest in,
or a change to their interest in, the Company under the FCA's Disclosure
Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it forms
part of domestic law of the United Kingdom by virtue of the European Union
(Withdrawal) Act 2018, the table below contains detailed information of the
individual trades made by Deutsche Numis as part of the Share Buyback
Programme:
Date of purchase Number of ordinary shares purchased Transaction price Time of transaction (UK Time) Transaction reference number Trading venue
(GBp share)
14 November 2024 2146 215.50 09:40:03 00072408159TRLO0 XLON
14 November 2024 1100 216.00 09:43:19 00072408362TRLO0 XLON
14 November 2024 2227 216.00 09:44:34 00072408375TRLO0 XLON
14 November 2024 380 216.50 11:22:01 00072411785TRLO0 XLON
14 November 2024 1724 216.50 11:22:01 00072411786TRLO0 XLON
14 November 2024 28 216.50 11:22:01 00072411787TRLO0 XLON
14 November 2024 520 216.50 11:22:01 00072411788TRLO0 XLON
14 November 2024 1941 216.50 11:32:15 00072411989TRLO0 XLON
14 November 2024 2274 216.50 11:32:15 00072411990TRLO0 XLON
14 November 2024 1 218.00 12:48:29 00072414057TRLO0 XLON
14 November 2024 1000 218.00 12:48:30 00072414058TRLO0 XLON
14 November 2024 1000 218.00 12:48:30 00072414059TRLO0 XLON
14 November 2024 1000 218.00 12:48:30 00072414060TRLO0 XLON
14 November 2024 699 218.00 12:48:30 00072414061TRLO0 XLON
14 November 2024 6 218.00 13:03:30 00072414354TRLO0 XLON
14 November 2024 539 218.00 13:03:30 00072414355TRLO0 XLON
14 November 2024 128 218.00 13:03:30 00072414356TRLO0 XLON
14 November 2024 762 218.00 13:03:30 00072414357TRLO0 XLON
14 November 2024 1156 218.00 13:36:59 00072415615TRLO0 XLON
14 November 2024 278 218.00 13:36:59 00072415616TRLO0 XLON
14 November 2024 2040 218.00 13:36:59 00072415617TRLO0 XLON
14 November 2024 278 218.00 13:36:59 00072415618TRLO0 XLON
14 November 2024 364 218.00 13:36:59 00072415619TRLO0 XLON
14 November 2024 3477 218.50 14:41:04 00072417958TRLO0 XLON
14 November 2024 693 218.50 14:41:04 00072417959TRLO0 XLON
14 November 2024 664 218.50 14:41:04 00072417960TRLO0 XLON
14 November 2024 863 218.50 14:41:04 00072417961TRLO0 XLON
14 November 2024 811 218.50 14:41:04 00072417962TRLO0 XLON
14 November 2024 1000 218.50 14:41:04 00072417963TRLO0 XLON
14 November 2024 238 218.50 14:41:04 00072417964TRLO0 XLON
14 November 2024 422 218.50 14:41:04 00072417965TRLO0 XLON
14 November 2024 401 218.50 14:41:04 00072417966TRLO0 XLON
14 November 2024 525 218.50 14:46:04 00072418328TRLO0 XLON
14 November 2024 1013 218.50 14:46:04 00072418329TRLO0 XLON
14 November 2024 532 218.50 14:46:04 00072418330TRLO0 XLON
14 November 2024 364 218.50 14:46:04 00072418331TRLO0 XLON
14 November 2024 161 218.50 14:46:04 00072418334TRLO0 XLON
14 November 2024 2061 218.00 14:47:03 00072418390TRLO0 XLON
14 November 2024 1170 218.00 15:12:05 00072419725TRLO0 XLON
14 November 2024 1036 218.00 15:12:05 00072419726TRLO0 XLON
14 November 2024 798 218.00 15:12:05 00072419727TRLO0 XLON
14 November 2024 781 218.50 15:40:32 00072421429TRLO0 XLON
This announcement will also be available on the Company's website at:
https://investors.spirehealthcare.com/news/regulatory-news/
Enquiries:
Spire Healthcare
Harbant Samra, CFO +44 (0)7881 672 365
Instinctif Partners
Julian Walker +44 (0)7825 189 696
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number 09084066
About Spire Healthcare
Spire Healthcare (http://www.spirehealthcare.com/) is a leading independent
healthcare group in the United Kingdom, running 38 hospitals and over 50
clinics, medical centres and consulting rooms across England, Wales and
Scotland. It operates a network of private GPs and provides occupational
health services to over 800 corporate clients.
Working in partnership with over 8,600 experienced consultants, Spire
Healthcare delivered tailored, personalised care to over 1 million inpatients,
outpatients and daycase patients, and occupational health programme clients,
in 2023, and is the leading private provider, by volume, of knee
(https://www.spirehealthcare.com/treatments/bones-and-joints/knee-replacement/)
and hip
(https://www.spirehealthcare.com/treatments/bones-and-joints/hip-replacement-surgery/)
operations in the United Kingdom. It also delivers a range of private and NHS
mental health, musculoskeletal and dermatological services under the Vita
Health Group brand.
Spire Healthcare's well-located and scalable hospitals have delivered
successful and award-winning outcomes, positioning the group well with
patients, consultants, the NHS, GPs and Private Medical Insurance ('PMI')
providers. 98% of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England, Wales and
Scotland.
Spire Healthcare is listed on the London Stock Exchange and is a member of the
FTSE 250.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSDZLFFZFLZFBD